We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+12.17%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$394B
AUM Growth
+$44.6B
Cap. Flow
+$6.63B
Cap. Flow %
1.68%
Top 10 Hldgs %
19.2%
Holding
3,619
New
44
Increased
2,356
Reduced
681
Closed
81

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Financials 12.41%
3 Healthcare 11.8%
4 Consumer Discretionary 10.03%
5 Industrials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBGI icon
2076
Sinclair Inc
SBGI
$1.03B
$8.45M ﹤0.01%
648,481
+13,874
+2% +$170K
SE icon
2077
Sea Limited
SE
$75.5B
$8.44M ﹤0.01%
208,482
-9,674
-4% -$395K
NWLI
2078
DELISTED
National Western Life Group, Inc. Class A
NWLI
$8.41M ﹤0.01%
17,420
+67
+0.4% +$31.9K
GLDD
2079
DELISTED
Great Lakes Dredge & Dock
GLDD
$8.38M ﹤0.01%
1,090,783
+40,679
+4% +$296K
EFC
2080
Ellington Financial
EFC
$1.76B
$8.37M ﹤0.01%
658,398
+111,314
+20% +$1.41M
KURA icon
2081
Kura Oncology
KURA
$896M
$8.34M ﹤0.01%
579,987
+16,566
+3% +$163K
WS icon
2082
Worthington Steel
WS
$1.94B
$8.34M ﹤0.01%
+296,745
New +$8.13M
CLDT
2083
Chatham Lodging
CLDT
$601M
$8.33M ﹤0.01%
776,939
+56,937
+8% +$569K
DCPH
2084
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$8.31M ﹤0.01%
515,301
+13,716
+3% +$175K
ERII icon
2085
Energy Recovery
ERII
$399M
$8.27M ﹤0.01%
439,205
+5,550
+1% +$103K
ESMT
2086
DELISTED
EngageSmart, Inc.
ESMT
$8.27M ﹤0.01%
361,061
+4,130
+1% +$91.6K
SG icon
2087
Sweetgreen
SG
$721M
$8.26M ﹤0.01%
731,369
+15,463
+2% +$163K
NVCR icon
2088
NovoCure
NVCR
$2.02B
$8.24M ﹤0.01%
551,775
+10,510
+2% +$141K
WTTR icon
2089
Select Water Solutions
WTTR
$2.63B
$8.22M ﹤0.01%
1,083,135
+136,489
+14% +$1.02M
SPHR icon
2090
Sphere Entertainment
SPHR
$6.33B
$8.22M ﹤0.01%
242,018
-13,606
-5% -$473K
SLYV icon
2091
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.12B
$8.21M ﹤0.01%
98,551
-14,207
-13% -$1.05M
NIC icon
2092
Nicolet Bankshares
NIC
$3.73B
$8.18M ﹤0.01%
101,665
+2,036
+2% +$152K
TDAY
2093
USA Today Co
TDAY
$1B
$8.18M ﹤0.01%
3,555,488
-91,104
-2% -$203K
HSII
2094
DELISTED
Heidrick & Struggles
HSII
$8.17M ﹤0.01%
276,703
+15,302
+6% +$406K
VICR icon
2095
Vicor
VICR
$10.4B
$8.16M ﹤0.01%
181,682
+9,297
+5% +$410K
JAMF
2096
DELISTED
Jamf
JAMF
$8.14M ﹤0.01%
450,836
+6,298
+1% +$106K
ANIP icon
2097
ANI Pharmaceuticals
ANIP
$1.72B
$8.11M ﹤0.01%
147,052
+63
+0% +$3.47K
GERN icon
2098
Geron
GERN
$982M
$8.11M ﹤0.01%
3,842,500
+208,170
+6% +$405K
QTRX icon
2099
Quanterix
QTRX
$135M
$8.09M ﹤0.01%
295,811
+28,784
+11% +$678K
VRDN icon
2100
Viridian Therapeutics
VRDN
$2.49B
$8.09M ﹤0.01%
371,311
+58,094
+19% +$917K

Similar funds

Charles Schwab's Q4 2023 Portfolio in Review

As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
  • Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
  • Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
  • Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
  • Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
  • Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
  • Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.

Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.